Skip to main content

Arcadia Biosciences, Inc.

corporate_fare Company Profile

Arcadia Biosciences, Inc.

RKDA·NASDAQ·Energy & Transportation·CIK 0001469443

Arcadia develops high-value products and drives innovation in the consumer goods industry. Since acquiring the assets of Zola in May 2021, Arcadia has provided consumers with Zola coconut water products for rehydration, resetting, and reenergizing. Previously, Arcadia developed products, primarily in wheat, which it commercialized through the sale of food products, trait licensing, and royalty agreements. On May 14, 2024, Arcadia sold its non-GMO Resistant Starch ("RS") durum wheat trait to Corteva Agriscience for total cash consideration of $4.0 million. On May 16, 2024, Arcadia sold the GoodWheat™ brand to Above Food for net consideration of $3.7 million. The assets sold consisted primarily of grain and finished goods inventories, formulations, and trademarks. On December 4, 2024, Arcadia, Roosevelt Resources LP, and Elliott Roosevelt, Jr. and David A. Roosevelt, as representatives of the limited partners of Roosevelt, entered into a Securities Exchange Agreement for the combination of the two companies in an all-stock transaction. Arcadia agreed to issue shares of its common stock to the limited partners and the sole member of the general partner of Roosevelt in exchange for all of the limited partnership and other equity interests of Roosevelt.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) is a publicly traded company in the Energy & Transportation sector. Wiseek has independently scored 23 items for RKDA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 18 rated 8 or above. Recent SEC coverage for RKDA spans 8-K, 10-Q, PRE 14A, 424B3.

Recent high-impact activity:

  • Arcadia Stockholders Approve Reverse Split and New Equity Plan
  • Second Nasdaq Delisting Notice Hits Arcadia Biosciences Over Equity Shortfall
  • Arcadia Biosciences Q2 Net Loss Widens to $6.27M on Financing Valuation Loss
  • Arcadia Biosciences Q2 Loss Widens to $6.27M; Going Concern and Nasdaq Delisting Risks Mount
  • Arcadia Biosciences Q2 Loss Widens to $6.3M, but Zola Sales Inflect with July Revenue Topping $740K

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.86M
Net Income
-$2.34M
Diluted EPS
-$1.71
Op. Cash Flow
-$4.74M
Free Cash Flow
-$4.74M
Gross Profit
$1.76M
Operating Income
-$2.5M
Cash & Equivalents
$259K
Debt / Equity
0.00×
Net Margin
-48.1%
Shares Outstanding
1.37M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197315

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 342,847 shares in RKDA as of the October 15, 2026 settlement, a 286.3% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 3, 2026, 18.9% of RKDA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)342,847 shares as of October 15, 2026
Change vs prior period▲ 286.3%
Days to cover1.00 at avg daily volume of 5,307,777
Daily short volume (FINRA facilities)18.9% of 59,363 shares on November 3, 2026
5-day average short volume36.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for RKDA, detected from its recent SEC filings · based on capital-structure filings through 2026-07-08.

1 shelf registration

Resale of 11.9 Million Shares Activated · Massive Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with R →
$0.1555 +0.32% today
52-week range · as of 2026-09-15 $0.1555 – $6.71
Market cap
$373.43K
Volume
112.3K (0.0× avg)
3-mo avg 4M
Live data · 2026-11-04 03:43 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed RKDA - Latest Insights

RKDA
Sep 15, 2026, 3:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.430
Real-time Price: $0.1555 info
Change: -$0.2745 (-64%) info
Market Cap: $373.428K info
RKDA
Sep 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4726
Real-time Price: $0.1555 info
Change: -$0.3171 (-67%) info
Market Cap: $373.428K info
RKDA
Aug 13, 2026, 4:20 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.5891
Real-time Price: $0.1555 info
Change: -$0.4336 (-74%) info
Market Cap: $373.428K info
RKDA
Aug 13, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.5699
Real-time Price: $0.1555 info
Change: -$0.4144 (-73%) info
Market Cap: $373.428K info
RKDA
Aug 13, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5699
Real-time Price: $0.1555 info
Change: -$0.4144 (-73%) info
Market Cap: $373.428K info
RKDA
Aug 07, 2026, 6:49 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.7154
Real-time Price: $0.1555 info
Change: -$0.5599 (-78%) info
Market Cap: $373.428K info
RKDA
Jul 31, 2026, 4:24 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.6202
Real-time Price: $0.1555 info
Change: -$0.4647 (-75%) info
Market Cap: $373.428K info
RKDA
Jul 08, 2026, 7:09 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.670
Real-time Price: $0.1555 info
Change: -$0.5145 (-77%) info
Market Cap: $373.428K info
RKDA
Jul 02, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.733
Real-time Price: $0.1555 info
Change: -$0.5775 (-79%) info
Market Cap: $373.428K info
RKDA
Jun 26, 2026, 4:32 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $0.6896
Real-time Price: $0.1555 info
Change: -$0.5341 (-77%) info
Market Cap: $373.428K info
RKDA
Jun 15, 2026, 11:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $0.1555 info
Change: -$0.8588 (-85%) info
Market Cap: $373.428K info
RKDA
Jun 12, 2026, 10:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.980
Real-time Price: $0.1555 info
Change: -$0.8245 (-84%) info
Market Cap: $373.428K info
RKDA
Jun 11, 2026, 8:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $0.1555 info
Change: -$1.01 (-87%) info
Market Cap: $373.428K info
RKDA
May 14, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $1.05
Real-time Price: $0.1555 info
Change: -$0.8975 (-85%) info
Market Cap: $373.428K info
RKDA
May 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.07
Real-time Price: $0.1555 info
Change: -$0.9145 (-85%) info
Market Cap: $373.428K info
RKDA
Apr 03, 2026, 3:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.38
Real-time Price: $0.1555 info
Change: -$1.22 (-89%) info
Market Cap: $373.428K info
RKDA
Mar 26, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
10
Price at Filing: $1.52
Real-time Price: $0.1555 info
Change: -$1.36 (-90%) info
Market Cap: $373.428K info
RKDA
Mar 26, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $0.1555 info
Change: -$1.36 (-90%) info
Market Cap: $373.428K info
RKDA
Mar 26, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.69
Real-time Price: $0.1555 info
Change: -$1.53 (-91%) info
Market Cap: $373.428K info
RKDA
Feb 10, 2026, 6:41 PM EST
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.80
Real-time Price: $0.1555 info
Change: -$1.65 (-91%) info
Market Cap: $373.428K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets